News November 2011

FONGIT attending the CleanTech Investing Seminar on Dec 7&8, 2011

Following our successful inaugural event, Campden Conferences is delighted to announce that the second annual CleanTech Investing Seminar will once again unite forward thinking investors with cutting edge cleantech companies seeking the vital investment they need to flourish in today’s continuously challenging economic climate. Along with a plethora of presentations from innovative cleantech companies and those all important one-to-one meetings for you to discuss new business opportunities, this year’s plenary and roundtable sessions have been comprehensively researched, updated and improved, focusing in particular on investment opportunities for significant families and their family offices. This unique event will unite family offices, private investors, blue chip corporations, and venture capital and private equity firms, presenting companies and will feature a stellar speaker line up of exceptional cleantech experts. Click on the below link to find out how you can become a delegate or innovative presenting company. Find out more about The CleanTech Investing Seminar

News Janvier 2010

Viroblock SA hires Dr. Jamie Paterson as CEO, and Closes Financing Round

Viroblock SA, a start-up dedicated to developing and commercializing a new generation of anti-viral products, today announced that Dr. Jamie Paterson will join Viroblock as Chief Executive Officer (CEO). Viroblock further announced that it has completed its second round of equity funding. The Series B financing round was led by Fongit Seed Invest SA, Peter Pfister, Initiative Capital Romandie SA (managed by DEFI Gestion) and BlueOcean Ventures acted as co-investo rs. Pour en savoir plus.

News Decembre 09

Augurix SA Closes Financing Round

Augurix Diagnostics (www.augurix.com), a medical diagnostics company specialized in the development of multiplex rapid in-vitro assays for Celiac Disease – also known as gluten intolerance – and associated conditions, is announcing the completion of CHF 620’000 in new financing. Existing investor FSI - Fongit Seed Invest (www.fongitseedinvest.ch) participated to this round, as well as a BlueOcean Ventures (www.blueocean-ventures.com), a new investor in the company.

Augurix was founded in 2007. Augurix was selected at the European Venture Contest 2007, finalist at the de Vigier prize in 2008 and obtained the CTI-startup Label the same year. The company’s first product, Simtomax® Blood Drop, based on its patented technology, is targeting the medical professional community. Simtomax® Blood Drop allows for the point-of-care screening of Celiac Disease, replacing the laboratory procedures being the norm until now.

Simtomax® Blood Drop has been successfully launched in Switzerland through a partnership with three nation-wide pharmacy groups. On July 1st, 2009, Augurix entered in agreement with US, Miami-based Ivax Diagnostics Inc, (AMEX:IVD) for the exclusive marketing and distribution of Simtomax® Blood Drop in 12 European countries.

Beginning 2010, Augurix is pursuing the expansion of its distribution network and actively working in the development of new diagnostics solutions focused on the predisposition assessment, screening and monitoring of Celiac Disease and associated conditions. Pour en savoir plus.

News Août 09

SalsaDev SA receives First Round of Equity Funding

SalsaDev SA, a start-up dedicated to developing and commercializing a new generation of OEM semantic tools for Finance, Legal and Content Providers, today announced that it has completed its first round of equity funding. Its semantic platform, Salsa, allows contextual and related searches, supervised or unsupervised classification and categorization, in information rich environments.

“I am delighted having access to a strong technical team in cognitive, semantic and data mining science, and experienced business people to help us building a strong company, which has great potential and future. We are now all excited to start deploying our first generation of semantic tools to our pilot customers I must thank for their strong commitment and trust, in spite of SalsaDev’s age.”, said Nicolas Gamard, CEO at SalsaDev.

In 2009, SalsaDev was awarded several prizes and recognitions for its ongoing commitment to innovation, including Venture Kick, Venture Leaders, CTI Coaching Acceptance, TechCrunch50 Finalist and Top 100 most promising start-ups in Switzerland. Pour en savoir plus.

News Janvier 08

Pour mieux servir ses startups, la Fongit est certifiée ISO 9001

La Fongit a confirmé la certification ISO 9001, déjà obtenue en 2007, attestant de l’existence d’un système de management de la qualité au sein de l’organisation. L’aptitude à fournir un produit conforme aux exigences du client ainsi que la recherche de sa satisfaction au moyen de l’amélioration continue, se trouvent au premier plan des exigences de la norme.

Concrètement, la norme ISO 9001 garantit l’établissement d’indicateurs de qualité comme la mesure de la satisfaction de la clientèle, composée en l’occurrence des entreprises coachées et des instances officielles qui subventionnent la Fongit, ou comme l’évaluation du taux de succès annuel, qui se mesure entre autres par le nombre d’emplois créés.